Financials data is unavailable for this security.
Cash flow in AUDView more
In 2024, Clarity Pharmaceuticals Ltd increased its cash reserves by 53.46%, or 16.69m. Cash Flow from Financing totalled 115.21m or -- of revenues. In addition the company used 43.24m for operations while cash used for investing totalled 55.31m.
Cash flow per share | -0.1544 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4694 |
---|---|
Tangible book value per share | 0.4694 |
More ▼
Balance sheet in AUDView more
Current ratio | 19.05 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼